A photo of Lori Luchtman-Jones.

Medical Director, Hemostasis & Thrombosis Laboratory

Director, Thrombosis Research

Medical Director, Division of Hematology

Professor, UC Department of Pediatrics



Board Certified

"I believe that people want to be healthy and strong, and by working together we can find a way forward. When patients, families and medical staff work together, the impossible can become possible."

My Biography & Research


I’m a board-certified pediatric hematologist-oncologist, or blood doctor. Early in my career I worked as an oncologist and bone marrow transplant doctor. I now specialize in pediatric hematology with a focus on hemostasis and thrombosis (blood clotting disorders). I am also a member of the Cerebrovascular Program at Cincinnati Children’s, where I work to improve the diagnosis and management of pediatric stroke.

I chose my career because I love children — especially adolescents and young adults. I am inspired by the honesty and courage of my patients. Having to take medicine every day or having limitations on activity or endurance is difficult. However, I believe that people want to be healthy and strong, and by working together we can find a way forward. When patients, families and medical staff work together, the impossible can become possible.

I am always looking for ways to improve outcomes. In addition to my clinical practice, I conduct research and direct a clinical laboratory where we look for solutions to bleeding and clotting problems. My team and I are trying to understand the connections between diseases like inflammatory disorders or sickle cell anemia and clotting. We also look for better ways to diagnose problems with platelet function.

Outside of the hospital, I enjoy cooking, growing herbs and reading mystery books. I also like to rehab old houses.

Additional Languages


Clinical Interests

Pediatric hematology: thrombosis; hemostasis; stroke

Research Interests

Thrombosis; stroke

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Cancer and Blood Diseases, Cerebrovascular, Cardio-Oncology, Hemophilia, Thrombosis

Research Divisions

Cancer and Blood Diseases, Hematology

My Locations

My Education

MD: University of California, San Diego, San Diego, CA, 1987.

Residency: Pediatrics, University of California San Diego School of Medicine, San Diego, CA, 1990.

Fellowship: Pediatric Hematology Oncology, Washington University in St. Louis School of Medicine/St. Louis Children’s Hospital, St. Louis, MO, 1994.

Certification: Pediatrics 1990; Pediatric Hematology Oncology, 1996 - present.

My Publications

The ASH-ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. O'Brien, SH; Badawy, SM; Rotz, SJ; Shah, MD; Makarski, J; Bercovitz, RS; Hogan, MJ S; Luchtman-Jones, L; Panepinto, JA; Priola, GM; et al. Pediatric Blood and Cancer. 2021; 68.

Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I. Grant, N; Taylor, JM; Plummer, Z; Myers, K; Burrow, T; Luchtman-Jones, L; Byars, A; Hammill, A; Wusick, K; Smith, E; et al. Frontiers in Pediatrics. 2021; 9.

Hydroxyurea Pharmacokinetics in Pediatric Patients After Total Pancreatectomy With Islet Autotransplantation. Boucher, AA; Dong, M; Vinks, AA; Marahatta, A; Howard, TA; Ware, RE; Nathan, JD; Abu-El-Haija, M; Luchtman-Jones, L. Journal of Clinical Pharmacology. 2021; 61:547-554.

Specifications of the variant curation guidelines for ITGA2B/ITGB3: ClinGen Platelet Disorder Variant Curation Panel. Ross, JE; Zhang, BM; Lee, K; Mohan, S; Branchford, BR; Bray, P; Dugan, SN; Freson, K; Heller, PG; Kahr, WH A; et al. Blood Advances. 2021; 5:414-431.

Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels. Schaefer, B; Hausfeld, A; Martin, M; Steele, P; Martin, J; Reher, SR; Lane, A; Luchtman-Jones, L. Pediatric Blood and Cancer. 2020; 67.

Extreme Thrombocytosis after Pediatric Pancreatectomy with Islet Autotransplantation Is Unique Compared to Other Postsplenectomy States. Boucher, AA; Luchtman-Jones, L; Palumbo, JS; Cancelas, JA; Abu-El-Haija, M; Jenkins, TM; Lin, TK; Nathan, JD. Journal of Pediatric Surgery. 2020; 55:1645-1650.

Influence of single parenthood on cardiopulmonary function in pediatric patients with sickle cell anemia. Zhang, X; Kershaw, KN; Minniti, CP; Campbell, A; Rana, SR; Darbari, DS; Luchtman-Jones, L; Sable, C; Dham, N; Ensing, G; et al. Blood Advances. 2020; 4:3311-3314.

Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study. Nouraie, M; Darbari, DS; Rana, S; Minniti, CP; Castro, OL; Luchtman-Jones, L; Sable, C; Dham, N; Kato, GJ; Gladwin, MT; et al. American Journal of Hematology. 2020; 95:766-774.

Hydroxyurea Pharmacokinetic Profiles in Children Treated for Extreme Thrombocytosis after Total Pancreatectomy with Islet Cell Autotransplant Demonstrate Poor Absorption. Boucher, AA; Dong, M; Marahatta, A; Hausfeld, A; Howard, TA; Nathan, JD; Vinks, AA; McGann, PT; Ware, RE; Luchtman-Jones, L. Blood. 2019; 134:4893-4893.

Aspirin in childhood acute ischemic stroke: The evidence for treatment and efficacy testing. Boucher, AA; Taylor, JM; Luchtnnan-Jones, L. Pediatric Blood and Cancer. 2019; 66.